United States
          Environmental Protection
          Agency
             Office of
             Solid Waste and
             Emergency Response
9200.6-303 (93-3)
NTIS No. PB-94-963302
EPA-504/R-94/017
November 1993
          Supertund
4>EPA
Health  Effects Assessment
Summary Tables
          Supplement Number 2 to the
          March 1993 Annual Update

-------
                                      9200.6-303(93-3)
                                      PB94-963302
                                      EPA 540/R-94/017
                                      November  1993
        HEALTH  EFFECTS ASSESSMENT

              SUMMARY TABLES


         FY-1993 Supplement No.  2
    Office of Research and  Development
Office of Emergency and Remedial Response
   U.S.  Environmental Protection Agency
         Washington,  D.C.  20460
       Region b, -_
       77 West Jackson no.^jfd, 12th Floor
       Chicago, IL 60604-3590

-------
                            DISCLAIMER
     This  report has  been  prepared  by  the U.S.  Environmental
Protection Agency.  The information contained herein has been taken
from final documents  prepared by the Office of Health and Environ-
mental Assessment  for the  Office of  Solid  Waste and  Emergency
Response and the Office of Water,  Washington, DC and the Office of
Air Quality  Planning and Standards,  Research Triangle  Park,  NC.
These documents were  reviewed in accordance with Agency policy and
approved for publication.   Mention of trade names or commercial
products does not constitute endorsement or recommendation for use.
                                11

-------
                        TABLE OP CONTENTS

                                                             Page


INTRODUCTION   	     1

WHAT'S NEW IN  THE NOVEMBER  1993 SUPPLEMENT  NO.  2	9

HEAST TABLE 1:  SUBCHRONIC  AND CHRONIC  TOXICITY
(OTHER THAN CARCINOGENICITY)   	    1-1

HEAST TABLE 3:  CARCINOGENICITY	    3-1

REFERENCES FOR HEAST TABLE  1:  SUBCHRONIC AND  CHRONIC
TOXICITY (OTHER THAN CARCINOGENICITY)      	   Rl-1

REFERENCES FOR HEAST TABLE  3:  CARCINOGENICITY   	   R3-1
                               111

-------
                           INTRODUCTION








     This document  is  the  November  1993  Supplement No.  2 for the



March 1993 Annual Update of the Health Effects Assessment Summary



Tables (HEAST) prepared by  EPA's Office of Health and Environmental



Assessment,   Environmental   Criteria   and  Assessment   Office,



Cincinnati,  OH  for  use  at  both  Superfund  and  RCRA  sites.



Supplement No. 2  updates the information  in  the March  1993 HEAST



Annual Update  and  Supplement No.  1  (July 1993).  When  using this



document, please refer to  the Annual Update and Supplement No. 1.



The supplements were not produced to stand alone and do not contain



the User's  Guides  or Appendix  that are  available  in  the Annual



Update.   Thus,  the user is strongly encouraged to reference the



March 1993 HEAST for this  information.



     The  HEAST  is  a   comprehensive   listing  consisting  almost



entirely of PROVISIONAL HEALTH EFFECTS INFORMATION  relative to oral



and inhalation routes for  chemicals of interest to Superfund, the



Resource Conservation  and  Recovery Act  (RCRA),  and the  EPA in



general.   These entries in  the HEAST are  limited to chemicals that



have undergone review and have the concurrence of individual Agency



Program  Offices,  and each is supported  by  an Agency reference.



This health effects information has not, however, had enough review



to  be   recognized  as  high  quality,   Agency-wide   consensus



information.



     The -integrated Risk Information System (IRIS)  is the Agency's



official repository of Agency-wide consensus chronic human health



risk information.  IRIS evaluations are conducted by the Agency's



Work Group Review process,  i.e.,  they have been examined  by either



                               -1-

-------
the Reference Dose/Reference Concentration (RfD/RfC)  Work Group or

the Carcinogen Risk Assessment Verification  Endeavor (CRAVE)  Work

Group.  These Agency Work Groups conduct  a  process  that leads to

internal  Agency  scientific  consensus  regarding  health  effects

information on a chemical.  This information is recorded on IRIS,

is considered to be "Work Group Verified", and does not appear on

the HEAST.   Thus,  provisional health effects  information  on the

HEAST is  subject  to possible  review  and revision  by these Agency

Work Groups.

     There are two exceptions to the above discussion.  The HEAST

also  contains information on  chemicals that  are  a part  of the

National  Ambient  Air Quality  Standards  (NAAQS) or the Drinking

Water Criteria Document (DWCD)  series.  In each of these cases, the

chemicals are subject to extensive scientific peer review processes

of extremely  high quality.



CHEMICAL  STATUS DEFINITIONS

      Chemicals  reviewed  by  the Agency Work Groups  are classified

according to  their  status as  either  "verified", "not verifiable",

or  "under review".  The  toxicity values (other than NAAQS  or DWCD

values)  listed on the HEAST  are  considered to be  "provisional."

The  Agency  has no  official  definitions for these  terms,  but the

HEAST user  may interpret them as  follows:


      Provisional:   A  toxicity value or a cancer  value  is
      "provisional" if  the value has  had  some  form of Agency
      review,  but  it does not appear on the IRIS system.  These
      values are generated  in several ways.   Often they are
      determined in the course of developing  an  Agency document
      on a chemical  or on a class of chemicals.   Some have been
      generated through the Work Group  process, but have not
      yet been  input  to  the  IRIS  system.  At the  time each

                                -2-

-------
value  was derived,  all available  information on  the
chemical  was  evaluated,  the  value was calculated  using
the roost current methodology, and a consensus was reached
on the value by Agency scientists.

Brackets  are  placed around  the names of  toxicity  and
carcinogenicity values on the HEAST to distinguish these
"provisional"  values from  information  on  IRIS.    The
following  names are affected:    RfD  to  [RfD] , RfC to
[RfC], slope factor to  [slope factor],  EPA group to  [EPA
Group] and unit risk to  [unit risk].

These "provisional" values are found on the HEAST.  They
do not appear on IRIS.

Verified:  A  toxicity value  or a cancer value is "Work
Group Verified" if  all available information on the value
has been examined by an  Agency Work Group, the  value has
been calculated using current Work Group methodology, a
unanimous consensus has  been reached on the value by the
Work Group, and the value appears on IRIS.

Some numbers  that  have  achieved unanimous consensus by
the Work Group may appear on the HEAST for a short time
until they are loaded onto IRIS, at which time they are
termed,  "verified."    During  the interim,   they  are
considered to be  "provisional"  values  that  are  still
"under review" by the Work Group.

These "verified" numbers only  appear  on  IRIS.  They do
not appear on the HEAST.

Not verifiable:  A  toxicity value is "not verifiable" if
an Agency Work Group has considered all available data on
a chemical and has unanimously determined that data are
inadequate to generate a value that would be suitable for
inclusion on IRIS.   No toxicity value is calculated; no
toxicity value is available for IRIS or  the HEAST.

This "not  verifiable" status is  noted on IRIS,  and is
sometimes found on the HEAST,  with a pointer to the  IRIS
system.

Under Review:  A toxicity value is "under review" if an
Agency Work Group  is in the  process of  considering all
available data on a chemical.  All Work  Group  chemicals
will have this status until the toxicity  value is placed
on the  IRIS  system.    Toxicity  values  that  have  been
withdrawn from  IRIS  by  a Work Group for further review
will have this status.

This "under review" status may be indicated on IRIS or on
the HEAST.    During  this time,  "provisional" toxicity
values may appear on the HEAST.
                          -3-

-------
     In all cases,  the status of  a chemical may change as new data



become available, and the assessment is revisited.








CAUTION



     It is imperative for each use>.r  of  the HEAST to recognize that



the values listed in the toxicity tables and the cancer table are



generally considered to be PROVISIONAL  HEALTH EFFECTS INFORMATION.



The user is referred to IRIS for  "Work  Group Verified" values.  It



is also  important  to remember that the numbers in  these tables



alone tell very little about the adverse effects of a chemical or



the quality  of evidence  on which health effects  information is



based.  Original  assessment documents must be consulted by users of



the HEAST in order  to  fully appreciate the  strengths and limita-



tions of  a  specific data  base.   Original  source  documents will



allow for the most  complete characterization of potential toxicity



associated with the range of exposure pathways generally evaluated



at Superfund and RCRA sites.  The Reference Tables point the user



to these sources.








CONTRIBUTORS



     Chemicals commonly  found at KCRA  sites as identified by the



Office  of Solid Waste's  (OSW)  Technical Assessment  Branch are



included  in the HEAST.    The Office  of Radiation  Programs has



provided data on radionuclide carcinogenicity for Tables 4A  and  4B



of the  HEAST.    Finally,  the Office of  Air Quality Planning and



Standards (OAQPS) has provided information  on chemicals  for  which



Air Quality  Criteria Documents  and National Ambient Air Quality



Standards have been  developed.



                               -4-

-------
CHEMICALS LISTED



     Most  of the chemicals  included  on the  toxicity  tables and



carcinoqenicity  table are those  for which  at least  one  of the



following EPA documents has been written:  Health Effects Assess-



ment  Document  (HEA),  Health  and  Environmental  Effects Profile



(HEEP),  Health  and  Environmental  Effects Document (HEED),  Health



Assessment  Document  (HAD), Air Quality Criteria Document (AQCD),



Drinking Water Criteria Document (DWCD).   A description of each  is



provided in Appendix A, Section I.   In a  few  cases, the values are



supported by other  written material, such as Work Group meeting



notes or Carcinogen Assessment Group (CAG)  Profiles.  Radionuclide



slope factor values  are calculated by the EPA's Office of Radiation



Programs.



     The  names  of.   criteria  pollutants  that  are  regulated   as



National Ambient Air Quality  Standards (NAAQS)  under  the Clean Air



Act are  listed  in  the main  body  of  the HEAST,   but  the actual



criteria  are included as  Section V of  Appendix  A:  Technical



Information.  The NAAQS were not included in the tables  in order  to



distinguish them from  the reference concentration  ([RfC]) values.



The NAAQS  and  [RfC]s represent different levels of  review and



different methods of calculation and thus, must be interpreted and



used differently.








HIERARCHY OF SOURCES



     It  is  recognized that  at any point in time  there  may  be



multiple old and  new Agency  documents or data bases that present



different values on a specific chemical.   For chemicals other than



those represented by the NAAQS or DWCDs, the following hierarchy  of




                               -5-

-------
sources  is  recommended  in  evaluating  chemical  toxicity  for

Superfund sites:


     1.  The  Agency's  Integrated  Risk  Information  System
         (IRIS) and  cited  references.   Changes  are  made in
         this data base on a monthly basis, but there may be
         data  gaps.    Call  RISK  INFORMATION  HOTLINE  at
         (513)569-7254 for further information.

     2.  The Health Effects Assessment Summary Tables (HEAST)
         and cited references.

     3.  Consultation with  the  Superfund  Health  Risk  Tech-
         nical Support Center (TSC) at (513)569-7300.

     4.  Do not consult either the toxicity tables (Appendix
         A) in the Superfund Public Health Evaluation Manual
         (SPHEM, U.S. EPA,  1986)  or the September  1988 Public
         Health Risk  Evaluation  Data Base  (PHRED)  as  these
         sources are  likely  tc contain  numerous values that
         have since become out-of-date.
QUESTIONS

Chemical Toxicity and Carcinogenicity

     Regional EPA Superfund  Staff  may direct questions regarding

the contents of the chemical toxicity and carcinogenicity tables on

the HEAST  (e.g.,  chemicals  not  covered, chemicals  with pending

[RfD]s) to  EPA's  Superfund Health Risk  Technical Support Center

(TSC)   in Cincinnati,  OH at  (513)569-7300.   Questions from other

users must be submitted to the TSC  in writing and must contain the

following information:


     •  Superfund site  name,  site  location  and  twelve-digit
        site number;

     •  Name and  phone number of  the site  Remedial  Project
        Manager (RPM) or Regional Risk Assessor/Toxicologist;

     •  Detailed description of the health effects information
        related question.
                                -6-

-------
     Please send requests via mail or FAX to:

      Superfund Health Risk Technical Support Center
      US EPA
      26 W. Martin Luther King Dr.
      Environmental Criteria and Assessment Office
      MS 117
      Cincinnati, OH  45268
      FAX#:   (513)569-7159


RCRA Chemicals

     Questions about RCRA chemicals may be addressed by calling the

Office of Solid Waste at  (202)260-4761.

Radionuclide Carcinogenicity

     Questions concerning radionuclide carcinogenicity should first

be  addressed  by  contacting the  appropriate  Regional  Radiation

Program Manager.  A listing of  these  managers and several contacts

in the Office of Radiation  Programs  can  be found in Exhibit 2 of

the User's Guide - Radionuclide Carcinogenicity.



REFERENCES

     Most cited Agency references (e.g.,  HEAs, HEEPs, HEEDs), are

(or  will  soon  be)   available through  the   National  Technical

Information Service (NTIS), 5285 Port Royal Road, Springfield, VA

22161 [(703)487-4650].  Carcinogen Assessment Group  (CAG) Profiles

cited  in  Table   3  are   available  through   the  RCRA   docket

(202)260-9327.

     Drinking water documents are available by calling the Drinking

Water Docket at (202)260-3027.

ORDERING INFORMATION

     Limited copies of  the HEAST  are available for EPA Superfund

staff,  State Superfund programs and  other Federal agencies  working
                               -7-

-------
on Superfund sites,  and EPA contractors working for the EPA Super-

fund program.   Users  in these groups can  call  Syracuse Research

Corporation (202)479-0881 to be put on the mailing list.

     EPA's Office of Solid  Waste  (OSW)  requests  that their users

(i.e., OSW staff, contractors, State solid waste programs) call the

Health Assessment Section  (202)260-4761 to obtain  copies  of the

HEAST.  Regional OSW staff are reminded that copies are sent to all

EPA Regional libraries.

     Users of the HEAST  in  EPA's  Office of Air  and  Radiation and

State air programs should call Kelly Rimer of EPA's Office of Air

Quality Planning and Standards at (919)541-2962.

     All other users must purchase the document from:

      National Technical Information Service (NTIS)
      5285 Port Royal Road
      Springfield,  VA  22161
      (703)487-4650


     For  ordering  information,  call   the  NTIS  Subscriptions

Department at (703)487-4630.  NTIS normally ships 4th class United

States mail.    Therefore,  users  may  wish  to  consult  with  NTIS

concerning the use of an overnight delivery service.  When ordering

the 1993 Health Effects Assessment Summary Table annual update and

supplements from NTIS refer to the following order numbers:

                 PB93-921100: Annual HEAST update and supplements

                 PB93-921199: Annual HEAST update

                 PB93-921101: July 1993 Supplement No. 1

                 PB93-921102: November 1993 Supplement No. 2
                               -8-

-------
          WHAT'S NEW IN THE FY93 NOVEMBER HEAST UPDATE

GENERAL CHANGES - CHEMICAL TOXICITY AND CARCINOGENICITY

     The changes in this  version  of  the HEAST reflect changes in
IRIS through October \,  1993.   It  is  also current with RfD/RfC and
CRAVE  Work Group  activities   through  October  1,  1993.   Cross-
references between  tables may refer the  user to the  March 1993
HEAST Annual Update  and the July 1993  Supplement No.  1 for that
information.

CHEMICAL-SPECIFIC CHANGES — CHEMICAL TOXICITY AND CARCINOGENICITY

A.   CHEMICAL-SPECIFIC CHANGES ON HEAST TABLE 1:   SUBCHRONIC AND
     CHRONIC TOXICITY (OTHER THAN CARCINOGENICITY)

Acrylonitrile  107-13-1
Added to Table 1.  The [RfD]  under  review by the RfD/RfC Work Group
was modified to derive the subchronic [RfD].

Arochlor 1248  12672-29-6
Added to Table 1.  A comment was added to indicate that the chronic
oral RfD  is  considered  not verifiable  (07/20/93) by the RfD/RfC
Work Group.

Atrazine  1912-24-9
An indicator was  added  to show that the chronic  oral RfD is now
available on  IRIS.  The  chronic oral RfD on IRIS was adopted  as the
subchronic oraj. [RfD] .

Barium cyanide  542-62-1
A  comment  was added  to  indicate that the  chronic  oral  RfD is
considered not verifiable  (07/20/93) by the RfD/RfC Work Group.

Benzenethiol / Thiophenol  108-98-5
Added to Table 1.  The [RfD]  under  review by the RfD/RfC  Work Group
was modified to derive the subchronic [RfD].

Boron  7440-42-8
No change in  the tables.  Reference to the 1993 Revised and Updated
Drinking Water Quantification of Toxicologic Effects  for Boron was
added.

Bromomethane  74-83-9
No change in  the tables.  Reference to the 1993 Revised and Updated
Drinking   Water   Quantification   of   Toxicologic   Effects   for
Bromomethane was added.

Chromium III  16065-83-1
The  subchronic  [RfD]   was changed  to agree  with  IRIS.     The
uncertainty  factor  was  changed  to  incorporate an  additional
Modifying factor of 10  as on IRIS.
                                -9-

-------
Cresol.  p- /  Methvlphenol.    4-106-44-5
Study information was  changed  to be consistent with  information
under review  by the  RfD/RfC work  group.  NOEL is changed to NOAEL,
critical effects are changed.  The chronic oral  [RfD] is adopted as
the subchronic oral [RfD].

Dicamba  1918-00-9
Added to Table 1.  An  indicator was added to show that the chronic
oral RfD is available  on IRIS.  The chronic  oral RfD was adopted as
the subchronic oral [RfD].

Dichloropropene. 1.3- / (Telone II)   542-75-6
No change in  the tables.  Reference to the 1993 Revised and Updated
Drinking  Water Quantification  of Toxicologic  Effects  for  1,3-
Dichloropropene was added.

Manganese  7439-96-5
No change in  the tables.  Reference to the 1993 Revised and Updated
Drinking Water Criteria Document for Manganese was added.

Methvl ethvl  ketone  000078-93-3
The subchronic oral  [RfD]  and  subchronic  inhalation  [RfC]  were
changed to be consistent with IRIS.

Methvl ethyl  ketone peroxide  1338-23-4
Added to Table 1.  A  comment was  added to indicate that the chronic
oral RfD  is  considered not verifiable  (07/22/93)  by the RfD/RfC
Work Group.

Methvl isobutvl ketone  108-10-1
The chronic oral [RfD] was changed to reflect the value currently
under review  by the RfD/RfC Work Group  (07/22/93) .   The chronic
oral [RfD] was modified to derive the subchronic oral  [RfD].

Metolachlor  051218-45-2
Added to Table  1 from the 1993 Revised and Updated Drinking Water
Quantification  of Toxicologic Effects for Metolachlor.

Nickel cyanide  557-19-7
Added to Table 1. A comment was added to indicate  that the chronic
oral RfD  is  considered not verifiable  (07/20/93)  by the  RfD/RfC
Work Group.

Osmium tetroxide  20816-12-0
Added to Table  1. A comment was added to indicate  that the chronic
oral RfD  is  considered not verifiable  (07/22/93)  by  the  RfD/RfC
Work Group.

Simazine  122-34-9
An  indicator was added to show  that the chronic oral  3fD  is now
available on IRIS.  The chronic oral RfD on IRIS was adopted as the
subchronic oral [RfD].
                               -10-

-------
Tetrachloroethane. 1.1.1.2-  630-20-6
No change  in the tables.  Reference to  1993  Revised and Updated
Drinking Water Quantification of Toxicologic Effects for
1,1,1,2-Tetrachloroethane was added.

Thallic oxide  1314-32-5
A  comment  was added to  indicate  that  the  chronic oral  RfD is
considered not verifiable (07/22/93) by  the RfD/RfC Work Group.

Thallium Selenite  12039-52-0
The RfD was  withdrawn from IRIS (08/93) . A  comment was added to
indicate that  the  chronic oral RfD  is  considered not verifiable
(07/22/93)  by the RfD/RfC Work Group.

Trichlorobenzene. 1.2f  4120-82-1
The inhalation [RfC] was removed from Table 2 and the  [RfC] under
review by the RfD/RfC Work Group was added to Table 1.  The [RfC]
under review by the RfD/RfC Work Group was modified to derive the
subchronic [RfC].

B.   CHEMICAL-SPECIFIC  CHANGES ON  HEAST TABLE 2:     ALTERNATE
     METHODS  —  SUBCHRONIC  AND  CHRONIC TOXICITY  (OTHER  THAN
     CARCINOGENICITY)

Trichlorobenzene. 1,2.  4120-82-1
The inhalation [RfC] was removed from Table 2 and the  [RfC] under
review by the RfD/RfC Work Group was added to Table 1.

C.   CHEMICAL-SPECIFIC CHANGES ON HEAST TABLE 3:   CARCINOGENICITY

Coke Oven Emissions  8007-45-2
An indicator was  added to show that the EPA group classification is
now on IRIS.

Cyanazine  21725-46-2
Study Information was revised (cancers  reported  and  the references
changed)  to reflect CRAVE Work Group review.

Dibromo-3-chloropropane. 1.2-  96-12-8
The  inhalation  [slope]  and  the   inhalation  [unit   risk]  were
inadvertently reversed on the July 1992  Supplement No. 1.

Dichloropropene.  1.3- /  (Telone II)   542-75-6
Study information was revised (cancers  reported  and  the references
changed)  to reflect the information currently under review by the
CRAVE Work Group.

Methylenebisbenzenamine. 4.4-  101-77-9
No  [EPA  group]  classification  was  provided  in  the reference
document;  therefore,  the oral  [slope]  and  the  [unit  risk]  were
removed from Table 3.
                               -11-

-------
Ethvlene thiourea  96-45-7
The oral [slope] factor and the oral  [unit  risk]  were changed to
reflect the values  currently under  review by the CRAVE Work Group.

Methyl hydrazine  60-34-4
The [EPA group] classification was added to Table 3.

Metolachlor  051218-45-2
Added to Table 3 from the 1993 Revised and Updated Drinking Water
Quantification of Toxicologic Effects for Metolachlor.

Mirex  2385-85-5
The oral [slope]  and the [unit risk] are under review by the CRAVE
Work Group and were removed from Table 3.

TCDD.  2.3.7.8-   001746-01-6
The units  for  the  Inhalation  [unit risk]  were  added  to Table 3.
There are no additional changes to the Table.

Tetrachloroethane.  1.1.1.2-  630-20-6
No change in the tables.  Reference to the  1993 Revised and Updated
Drinking Water Quantification of Toxicologic Effects for
1,1,1,2-Tetrachloroethane was added.

Trichloropropane. 1.2.3-  96-18-4
The oral [slope]  and the [unit risk] under  review by  the CRAVE Work
Group were added to Table 3.


D.   CHANGES   ON   HEAST  TABLES    4A   AND    4B:   RADIONUCLIDE
     CARCINOGENICITY — SLOPE FACTORS

No new radionuclide slope  factors  were  added to Tables 4A and 4B
and none of the slope factors  listed in the March 1993  HEAST Annual
Update were changed.
                               -12-

-------
                          HEAST TABLE 1: SUBCHRONIC AND CHRONIC TOXICITY (OTHER THAN CARCINOGENICITY)
                                                                                                                                Novenfcer 1993
 CHEMICAL  DOSE
 LEVEL     ROUTE
                         SPECIES
                     EXPERIMENT LENGTH  TARGET
 ACRYLONITRILE
 NOAEL   1     MG/(KG-DAY)

        ORAL:  GAVAGE
                                                     CRITICAL EFFECT

                                          000107-13-1
                                                                               Subchronic             Chronic
                                                                                       [RfD]       [RfC]       [Rfp]    REFERENCE
                                                                          (ma/cu n\)  (mg/ka/day)   (mfl/cu m) (mg/kg/dav)
                                                                                        UF         UF        UF
                                                                                     UF
                        HOUSE
                        60 DAY
                                     TESTES
                                     TESTES
                                                    DECREASED SPERH COUNTS
                                                    SEMINIFEROUS TUBULE
                                                    DEGENERATION
                                                                                      1E-2
                                                                                       100
1E-3
 1000
        GENERAL  COMMENT:   ALSO SEE HEAST TABLE 3:  CARCINOGENICITY
        SUBCHRONIC  [RfD] COMMENT:  THE CHRONIC [RfD] UNDER REVIEW BY THE WORK GROUP WAS MODIFIED TO DERIVE THE  SUBCHRONIC [RfD]


AROCHLOR 1248                         012672-29-6

        CHRONIC  [RfDJ COMMENT:  THE CHRONIC ORAL  RfD IS CONSIDERED NOT VERIFIABLE (07/20/93)  BY THE RfD/RfC WORK GROUP.


                                       001912-24-9
ATRAZINE
NOEL    3.5  MG/KG/DAY

        ORAL: DIET
                        RAT
                        2  YEARS
                                    WHOLE BODY
                                                    DECREASED WEIGHT GAIN
                                                                                             3.5E-2
                                                                                             100
                                                                                                                  IRIS
        SUBCHRONIC [RfD]  COMMENT:  THE CHRONIC ORAL RFD WAS ADOPTED AS THE SUBCHRONIC ORAL  [RfD].


BARIUM CYANIDE                         00054;'-62-1


        CHRONIC  [RfD]  COMMENT:  THE CHRONIC ORAL RfD IS CONSIDERED NOT VERIFIABLE (07/20/93) BY THE RfD/RfC WORK GROUP.


                                           000108-98-5
BENZENETHIOL
(THIOPHENOL)
LOAEL    0.1    MG/KG-DAY)
                       RAT
                       90 DAYS
                                                   CENTRILOBULAR
                                                   EOSINOPHILIC CHANGES
                                                                                             1E-4
                                                                                             1000
ORAL:  GAVAGE     90 DAYS       LIVER


SUBCHRONIC  [RfD]  COMMENT:  THE  CHRONIC [RfD] UNDER REVIEW  BY THE WORK GROUP WAS MODIFIED  TO DERIVE THE  SUBCHRONIC [RfD]
1E-5
10,000
010939
                                                                                                                            010940
                                                                                                                            010855
                                                                                                                            0,0941
010942
IRIS, EPA'S INTEGRATED RISK INFORMATION SYSTEM, IS UPDATED MONTHLY.  FURTHER INFORMATION: RISK INFORMATION HOTLINE:  (513) 569-7254.

-------
                          HEAST TABLE 1: SUBCHRONIC AND CHRONIC TOXICITY (OTHER THAN CARCINOGENICITY)      Novenfcer 1993
 CHEMICAL  DOSE
 LEVEL     ROUTE
     SPECIES
EXPERIMENT LENGTH TARGET
                                                      CRITICAL  EFFECT
                                    Subchronic             Chronic
                                            [RfD]       [RfC]       [RfD]    REFERENCE
                               (mg/cu m)  (mg/lcg/day)  (mg/cu m) (mg/kg/day)
                                  UF         UF          UF        UF
 BORON, ELEMENTAL
 LOAEL    4.5    MG/CU M

         INHALATION:
         INTERMITTENT
                         007440-42-8
   HUMAN
                 RESPIRATORY
                 TRACT
                 BRONCHUS
                                 IRRITATION
                                                      BRONCHITIS
                                2E-2
                                100
2E-2
100
005269
        SUBCHRONIC [RfC] COMMENT:      THE SUBCHRONIC [RFC] IS SPECIFICALLY FOR ANHYDROUS  BORAX.
        CHRONIC IRfC)  COMMENT:  THE CHRONIC  [RFC]  IS SPECIFICALLY FOR  ANHYDROUS BORAX.
NOAEL   8.8    MG/KG/DAY

        ORAL: DIET
   DOG
   2 YEARS
                                      TESTIS
LESIONS
                                                                                               96-2
                                                                                               100
        SUBCHRONIC  [RfD] COMMENT:
                THE LHRONIC ORAL RfD WAS ADOPTED AS THE SUBCHRONIC ORAL [RfD] .
                                                                                               IRIS
                                                                                                         005272
BROMOMETHANE
                        000074-83-9
                                                                                                          IRIS
                                                                                                                              010860
                                                                                                                    IRIS
                                                                                                                              010861
        SUBCHRONIC  [RfO] COMMENT:   CONTACT THE SUPERFUND HEALTH  RISK TECHNICAL SUPPORT CENTER: (513)  569-7300.
        SUBCHRONIC  [RfC] COMMENT:   CONTACT THE SUPERFUND HEALTH  RISK TECHNICAL SUPPORT CENTER: (513)  569-7300.
                                                                                                         010880
CHROMIUM(III)
NOEL    5      X

        ORAL:  DIET
                     01606b-83-1
   RAT
   840  DAYS
NONE  OBSERVED
                                          1E+0
                                          1000
        CHRONIC  [RfC] COMMENT:   INHALATION ISSUES ARE UNDER REVIEW BY THE RFD/RFC  WORK GROUP.
        SUBCHRONIC  [RfD] COMMENT:      THE CHRONIC ORAL RfD WAS ADOPTED AS THE SUBCHRONIC ORAL [RfD].

        SUBCHRONIC  [RfC] COMMENT:   CONTACT THE SUPERFUND HEALTH RISK TECHNICAL SUPPORT CENTER: (513)  569-7300.
                                                                                                                    IRIS
                                                                                                         005731
                                                                                                         010886
IRIS,  EPA'S  INTEGRATED RISK  INFORMATION SYSTEM, IS UPDATED MONTHLY. FURTHER  INFORMATION: RISK  INFORMATION HOTLINE:  (513) 569-7254.
                                                                                                                                           1-2

-------
                          HEAST TABLE 1 :  SUBCHRONIC AND CHRONIC TOXICITY (OTHER THAN CARCINOGENICITY)     Nove^r  1993
CHEMICAL  DOSE            SPECIES                                                    [RfCJ^   ^"'[RfD]       [RfC        fRfDl    RFFFRFMfF
LEVEL     ROUTE       EXPERIMENT LENGTH  TARGET           CRITICAL EFFECT
                                                                                      UF         UF         UF         UF


CRESOL, P-                            000106-44-5
(METHYLPHENOL, 4-)
NOAEL   5     MG/(KG-DAY)
                        RABBIT
        ORAL:  GAVAGE     GESTATION     CENTRAL  NERVOUS  HYPOACTIVITY                               5E-3                  5E.j       010516
                        DAYS 6-18     SYSTEM                                                    1000                  1000
                                     RESPIRATORY      DISTRESS
                                     SYSTEM
                                     WHOLE BODY       MATERNAL DEATH

        SUBCHRONIC  [RfD] COMMENT: THE CHRONIC ORAL  [RfO] WAS ADOPTED AS THE SUBCHRONIC ORAL [RfD].

                                                                                                         IRIS                  010890

        CHRONIC  [RfCJ COMMENT:   THE CHRONIC INHALATION  [RfC]  IS CONSIDERED NOT  VERIFIABLE (12/11/91)  BY THE RfD/RfC  WORK  GROUP
        GENERAL  COMMENT:  ALSO SEE HEAST TABLE  3: CARCINOGENICITY.


DICAMBA                               001918-00-9
NOAEL   3     MG/KG/DAY
                        RABBIT
        ORAL:  GAVAGE     GESTATION     FETUS           DECREASED WEIGHT                           3E-2                  IRIS       010945
                        DAYS 6-18     FETUS           INCREASED POST-                            100
                                                     IMPLANTATION LOSSES
                                     FETUS           INCREASED MORTALITY
                                     DAM             DECREASED WEIGHT GAIN

        SUBCHRONiC  [RfD] COMMENT:  THE CHRONIC  ORAL RfD WAS ADOPTED AS THE SUBCHRONIC ORAL [RfD].
IRIS,  EPA'S INTEGRATED RISK  INFORMATION SYSTEM, IS UPDATED MONTHLY. FURTHER  INFORMATION:  RISK  INFORMATION HOTLINE:  (513) 569-7254.                 1-3

-------
                         HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY (OTHER THAN CARCINOGENICITY)     Noveni*>r 1993
CHEMICAL  DOSE
LEVEL    ROUTE
                 SPECIES
             EXPERIMENT LENGTH  TARGET
                CRITICAL EFFECT
                                   Subchronic            Chronic
                                           (RfDJ      [RfC]       [RfD]    REFERENCE
                             (mfl/cu m)   (nig/ka/dav)   (mg/cu m) (mg/kg/day)
                                 UF         UF         UF        UF
DICHLOROPROPENE, 1.3-
(TELONE  II)
NOEL    3     ::G/KG/DAY
                        RAT
        ORAL: DIET       90 DAYS
                                      000542-75-6
                             ORGANS
                                             INCREASED  WEIGHT
        GENERAL COMMENT:  ALSO SEE HEAST  TABLE 3:  CARCINOGENICITY.
                                                        3E-3
                                                        1000
                                                                                                                 IRIS
                                                                                                                           005901
NOAEL
5     PPM

INHALATION:
INTERMITTENT
                       MOUSE
                       2 YEARS
NASAL MUCOSA
NASAL MUCOSA
HYPERTROPHY
HYPERPLASIA
2E 2
30
                                                                                                       IRIS
                                                                                                                           010351
        SUBCHRONIC [RfC] COMMENT:
                             THE CHRONIC  INHALATION RfC UAS ADOPTED AS THE SUBCHRONIC INHALATION  [RfC].
                     RISK INFORMATION SYSTEM, IS UPDATED MONTHLY.  FURTHER INFORMATION: RISK  INFORMATION  HOTLINE: (513) 569-7254.

-------
                          HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY (OTHER THAN CARCINOGENICITY)      Novenfcer 1993
CHEMICAL  DOSE
LEVEL     ROUTE
     SPECIES
EXPERIMENT LENGTH TARGET
                                                      CRITICAL EFFECT
                                    Subchronic             Chronic
                               [RfC]         [RfD]       [RfC]       [RfO]    REFERENC;
                              (mg/cu m)  (mg/kg/day)  (mg/cu m) (mg/kg/day)
                                  UF          UF          UF         UF
MANGANESE
NOAEL   O.U   MG/KG/DAY
                         HUMAN
        ORAL: DIET       CHRONIC
        SUBCHRONIC [RfD] COMMENT:
        INFORMATION.
                      007439-96-5
                 CENTRAL          EFFECTS
                 NERVOUS SYSTEM
                                          1.4E-1
                                          1
                                                                                                                     IRIS
                                                                                            010851


THE CHRONIC ORAL FOOD RfD ON  IRIS  IS ADOPTED AS THE  SUBCHRONIC ORAL FOOD [RfD].   SEE  IRIS FOR SPECIFIC  DIETARY
NOAEL   0.005   MG/KG/DAY
                        HUMAN
        ORAL: DRINKING   CHRONIC
        WATER

        SUBCHRONIC [RfD] COMMENT:
        INFORMATION.
                 CENTRAL          EFFECTS
                 NERVOUS SYSTEM
                                          5E-3
                                          1
                                                                                  IRIS
                                                                                            010850
               THE CHRONIC ORAL WATER  RfD ON  IRIS IS ADOPTED  AS  THE SUBCHRONIC ORAL  WATER  (RfO) .  SEE IRIS FOR  SPECIFIC DIETARY
LOAEL   0.97   MG/CU M

        INHALATION:
        INTERMITTENT
   HUMAN
                 LUNG
                 CENTRAL
                 NERVOUS SYSTEM
RESPIRATORY  EFFECTS
PSYCHOMOTOR  DISTURBANCES
                                                  4E-A
                                                  900
                                                                                      IRIS
                                                                                                           010355
        SUBCHRONIC [RfC] COMMENT:      THE CHRONIC INHALATION  RfC ON IRIS IS ADOPTED AS  THE SUBCHRONIC INHALATION  [RfC].
        GENERAL COMMENT:  OCCUPATIONAL  EXPOSURE. DURATION OF EMPLOYMENT RANGED FROM 1-19 YEARS WITH A MEAN OF  7.1  YEARS.
IRIS,  EPA'S  INTEGRATED RISK INFORMATION SYSTEM. IS UPDATED MONTHLY. FURTHER INFORMATION: RISK INFORMATION  HOTLINE: (513) 569-7251.
                                                                                                                                             1-5

-------
 CHEMICAL  DOSE
 LEVEL     ROUTE
HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY (OTHER THAN CARCINOGENICITY)     November 1993

                                                               Subchronic             Chronic
                                                          [RfC]         TRfni      ratr
                            CRITICAL EFFECT
                  SPECIES
             EXPERIMENT LENGTH  TARGET
                                                                                 [RfD]    REFERENCE
                                              (mg/cu m)  (mg/kg/dav)   (mg/cu m) Img/kg/day)
                                                 UF         UF         UF         UF
 METHYL ETHYL KETONE
 NOAEL   1711   MG/KG/DAY
                        RAT
        ORAL: DRINKING   MULTI-GENERA  FETUS
        WATER           TION
                                            000078-93-3


                                              DECREASED BIRTH WEIGHT
                                                                                       2E+0
                                                                                       1000
                                                                               IRIS
                                                                                                    010853
        SUBCHRONIC  [RfD] COMMtNT:       THE CHRONIC ORAL  RfD WAS MODIFIED TO ESTIMATE THE  SUBCHRONIC ORAL  [RfD]
        GENERAL COMMENT:  HULTI-GENERATION DEVELOPMENTAL STUDY PERFORMED WITH THE SURROGATE 2-BUTANOL,  A  METABOLITE OF METHYL  ETHYL KEfONE.
NOAEL   1010   PPM

        INHALATION:
        INTERMITTENT
                MOUSE
                10 DAYS
        SUBCHRONIC  [RfC] COMMENT:
FETUS            DECREASED BIRTH WEIGHT           1E»0                 IRIS
                                               JOOO

THE  CHRONIC INHALATION RfC ON IRIS IS  ADOPTED AS THE SUBCHRONIC INHALATION  [RfC].
                                                                                                                      010845
METHYL ETHYL KETONE PEROXIDE              001 338-23-4

        CHRONIC  [RfD] COMMENT:   THE CHRONIC ORAL  RfD  IS CONSIDERED NOT VERIFIABLE  (07/22/93) BY THE  RfD/RfC WORK GROUP.
                                                                                                                      010948
METHYL ISOBUTYL KETONE
NOAEL    250   MGX(KG-DAY)
                        RAT
        ORAL:  GAVAGE     13 WEEKS
                                         000108-10-1


                             WHOLE BODY       LETHARGY                                  8E-1                  8E-2       010949
                             LIVER           INCREASED  RELATIVE                         300                   3000
                                             WEIGHT,  FEMALES
                             LIVER           INCREASED  ABSOLUTE
                                             WEIGHT,  FEMALES
                             KIDNEY          INCREASED  RELATIVE
                                             WEIGHT,  FEMALES

                             KIDNEY          INCREASED  ABSOLUTE
                                             WEIGHT,  FEMALES
                             KIDNEY          INCREASED  URINARY PROTEIN
                                             LEVELS,  FEMALES

SUBCHRONIC  [RfC] COMMENT:      ALSO SEE HEAST TABLE 2: ALTERNATE METHODS -  SUBCHRONIC AND CHRONIC TOXICITY (OTHER  THAN CARCINOGENICHY)
CHRONIC  [RfC] COMMENT:  ALSO SEE HEAST TABLE 2: ALTERNATE  METHODS - SUBCHRONIC AND CHRONIC TOXICITY (OTHER THAN CARCINOGENICITY)
CHRONIC  [RfD] COMMENT:  WITHDRAWN FROM IRIS (3/1/91). UNDER REVIEW, CURRENT NUMBER SUBJECT TO CHANGE.
                                      -~^ru  ic iiDn»Tcn unuTMiv  FIIBTHFR  INFORMATION:  RISK  INFORMATION HOTLINE: (513) 569-7254.
                                                                                                                                           1-6

-------
                         HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY (OTHER THAN CARCINOGENICITY)     Noventer 1993
 CHEMICAL  DOSE
 LEVEL     ROUTE
                         SPECIES
                    EXPERIMENT LENGTH  TARGET
                                                    CRITICAL EFFECT
                                  Subchronic             Chronic
                                          CRfD]      [RfC]       [RfD]    REFERENCE
                             (itig/cu tn)  (mg/kg/dav)  (mg/cu  m) (mg/kg/dav)
                                UF         UF         UF        UF
METOLACHLOR
NOAEL   300    PPM
                                           051218-45-2
                        RAT
                                                                                            1.5E-1
                                                                                            100
        ORAL: DiET      2 YEARS      WHOLE  BODY      DECREASED  WEIGHT GAIN


        CHRONIC [RfD]  COMMENT:  THE CHRONIC ORAL [RfD] WAS ADOPTED AS THE SUBCHRONIC ORAL  {RfD}.


NICKEL CYANIDE                        000557-19-7


        CHRONIC [RfD]  COMMENT:  THE CHRONIC ORAL RfD IS CONSIDERED NOT VERIFIABLE (07/20/93) BY THE RfD/RfC WORK GROUP.


OSMIUM TETROXIDE                      020816-12-0

        CHRONIC [RfD]  COMMENT:  THE CHRONIC ORAL RfD IS CONSIDERED NOT VERIFIABLE (07/22/93) BY THE RfD/RfC WORK GROUP.
                                                             1.5E-1
                                                             100
                              010950
                                                                                                                          010953
                                                                                                                          010954
SIMAZ1NE
NOAEL   0.52
                                       000122-34-9
              MG/KG/DAY
        ORAL: DIET
                       RAT
                       2 YEARS
                                    WHOLE  BODY
                                    BLOOO
DECREASED WEIGHT  GAIN
HEMATOLOGICAL EFFECTS
                                                                                            5E-3
                                                                                            100
        SUBCHRONIC [RfD] COMMENT:   THE CHRONIC ORAL RfD  WAS ADOPTED AS THE SUBCHRONIC ORAL [RfD].
        GENERAL COMMENT:  ALSO SEE  HEAST TABLE 3: CARCINOGENICITY.
                    IRIS
010955
TETRACHLOROETHANE, 1,1,1,2-
NOAEL    89.3   MG/KG/DAY
        ORAL:  GAVAGE    RAT
                       103 WEEKS
        SUBCHRONI" [RfD] COMMENT:
                                    LIVER
                                    KIDNEY
                                                 000630-20-6
LESIONS
LESIONS
3E-2
3000
                                    THE CHRONIC ORAL RfD WAS ADOPTED AS THE SUBCHRONIC ORAL [RfD].
                                                                                                                IRIS
                                                                                                                          010407
IRIS,  EPA'S INTEGRATED RISK INFORMATION SYSTEM, IS UPDATED MONTHLY. FURTHER  INFORMATION:  RISK INFORMATION HOTLINE:  (513) 569-7254.
                                                                                                                                       1-7

-------
                        HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY (OTHER THAN CARCINOGENICITY)     November 1993
CHEMICAL  DOSE
LEVEL     ROUTE
                 SPECIES
            EXPERIMENT LENGTH TARGET
CRITICAL EFFECT
     Subchronic             Chronic
 [RfC]        [RfD]      [RfC]       [RfD]    REFERENCE
(mg/cu m)  (nig/kg/day)  (mg/cu m) (mg/kg/day)
   UF        UF          UF         UF
THALLIC OXIDE
                                 001314-32-5
        CHRONIC [RfD] COMMENT:   THE CHRONIC ORAL RfD IS CONSIDERED NOT VERIFIABLE (07/22/93) BY THE RfD/RfC WORK GROUP.
THALLIUM SELENITE
                                    012039 52-0
        CHRONIC [RfD] COMMENT:   THE CHRONIC ORAL RfD  IS CONSIDERED NOT VERIFIABLE (07/22/93) BY THE RfD/RfC WORK GROUP.
                                                                                                                          010956
                                                                                                                          010957
TRICHLOROBENZENE, 1,2,4-
NOEL     100    PPM
                                       000120-82-1
                       RAT
                                    ADRENAL         INCREASED WEIGHT


        CHRONIC [RfD] COMMENT:   BASED ON A  MULT I GENERATION REPRODUCTION STUDY.
ORAL: DRINKING
WATER
                                        1E-2
                                        1000
                                                                                                        IRIS
                                                                                                                  010506
NOAEL    104    PPM
        INHALATION
                       RAT,  RABBIT,
                       DOG,  MONKEY
                       6 & 26 WEEKS  LIVER
                                            NON-ADVERSE WEIGHT
                                            CHANGES
                              2E+0
                              100
                     2E-1
                     1000
                                                                                                                  010958
                          lumUMATlON SYSTEM. IS UPDATED MONTHLY. FURTHER  INFORMATION: RISK INFORMATION  HOTLINE: (513) 569-7254.
                                                                                                                                      1-8

-------
                                                      HEAST TABLE 3:  CARCINOGENICITY                                  Novo*er  1993
                                                                                   LOLurc  r flu I UK j
                   EXPERIMENT LENGTH                                     (EPA      ORAL    INHALATION      ORAL     IMHAlATnai  etttoFurf
CHEMICAL  ROUTE          SPECIES     TARGET               CANCEB           rj>n»i  ,-,»*,A~.I',..:,£,^i    7^,. . i  I"^1*1'?". REFEREMCE
                                                                                   ISLOPE  FACTOR]           [UNIT RISK]
                      	                                     	      _OAL     INHALATION     ORAL     INHALAiiui
                       SPECIES     TARGET               CANCER           GROUP]  (^/kg/day) '(-a/kg/dey)'    (ug/L)1  (ug/ol i£l

COKE OVEN EMMISSION                     008007-45-2
                                                                       IRIS


CYANAZINE                           021725-46-2
        ORAL: DIET      2 YEARS                                         C       8.4E-1                    2 4E-5              010944
                       RAT          MAMMARY GLAND        ADENOMA/
                                                        CARCINOMA,
                                                        COMBINED

        GENERAL COMMENT:  ALSO SEE  HEAST TABLE 1: SUBCHRONIC AND CHRONIC  TOXICITY (OTHER THAN CARCINOGENICITY)

DIBROMO-3-CHLOROPROPANE, 1,2              000096-12-8
        INHALATION:                                                      B2                2.4E-3                   6.9E-7     010519
        INTERMITTENT
                       RAT, MOUSE    NASAL  CAVITY         TUMORS

        EPA GROUP COMMENT:   UNDER  REVIEW,  CLASSIFICATION SUBJECT TO CHANGE.
IRIS, ERA'S INTEGRATED RISK INFORMATION SYSTEM IS UPDATED MONTHLY.  FURTHER INFORMATION: RISK INFORMATION HOTLINE: (513) 569-7254.                 3-1

-------
                                                        HEAST TABLE 3: CARCINOGENICITY
                                                                                                                                   November 1993
 CHEMICAL  ROUTE
            EXPERIMENT LENGTH
                 SPECIES      TARGET
                                                         CANCER
                             CSLOPE  FACTOR!           [UNIT RISK]
                 [EPA       ORAL     INHALATION      ORAL     INHALATION  REFERENCE
                 GROUPJ (*9/kg/day)'(BB/kB/doY)1    (ifl/L)1  (UB/CU .)'
 DICHLOROPROPENE 000542-75-6
         (TELONE II)
         ORAL: GAVAGE     104 WEEKS
                                                                          IRIS
                                                                          1.8E-1
        ORAL: GAVAGE
RAT, MALE




104 WEEKS
MOUSE,
FEMALE




LIVER


FORESTOMACH


BLADDER
RESPIRATORY
SYSTEM

FORESTOMACH

NEOPLASTIC
NODULE/
CARCINOMA
PAPILLOMA/
CARCINOMA

CARCINOMA
ALVEOLAR/
BRONCHIOLAR
ADENOMA
PAPILLOMA/
CARCINOMA
                                                                                                           5E-6
                                                                                                                               010946
        ORAL [SLOPE] COMMENT:  THE fSLOPEJ  IS THE GEOMETRIC MEAN OF SLOPE  FACTORS OF COMBINED  URINARY BLADDER CARCINOMA  ALVEOLAR/BRONCHIOLAR
        ADENOMA,  FORESTOMACH PAPILLOMA/CARCINOMA IN FEMALE B6C3F1 MICE  AND  COMBINED HEPATOCELcULAR NEOPLASTIC NODULE AND/OR CARCINOMA AND  FORESTOMACK
        PAPILLOMA/CARCINOMA IN HALE F344 RATS.
        INHALATION:
        INTERMITTENT
                        2 YEARS
                        MOUSE
                                                                          IRIS
                                                                                    1.3E-1
                                                                                                            3.7E-5
                                                                                                                       010104
                                      LUNG
                                                         ADENOMA
        INHALATION  [SLOPE] COMMENT:   SEE APPENDIX A-II, DOSE CONVERSIONS ON HEAST.
        GENERAL COMMENT:  ALSO SEE  HEAST TABLE 1: SUBCHRONIC AND CHRONIC TOXICITY (OTHER  THAN CARCINOGENICITY).
ETHYLENE THIOUREA
        ORAL: DIET       2 YEARS
                        MOUSE,
                        FEMALE
                                      000096-45-7
                                                                         1.1E-1
                              LIVER
ADENOMA/
CARCINOMA,
COMBINED
                                                                                                  3.4E-6
                                                                                                                       010947
        ORAL  [SLOPE] COMMENT:   UNDER  REVIEW, NUMBER  SUBJECT TO CHANGE.
        GENERAL COMMENT:  ALSO SEE  HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY (OTHER  THAN CARCINOGENICITY).
METHYLENEBISBENZENAMINE, 4,
                                      00101-77-9
                                                                                                                            010136

GENERAL  COMMENT:  THE ORAL  [SLOPE] AND THE [UNIT RISK]  WERE  REMOVED BECAUSE THE  EPA GROUP CLASSIFICATION HAS NOT YET  BEEN DETERMINED.
IRIS,  EPA'S  INTEGRATED RISK  INFORMATION SYSTEM  IS UPDATED MONTHLY. FURTHER INFORMATION: RISK INFORMATION HOTLINE:  (513)  569-7254.
                                                                                                                                   3-2

-------
                                                       HEASTTABLE3:  CARCINOGENICITY
                                                                                                                                 Novofcer 1993
CHEMICAL  ROUTE
EXPERIMENT LENGTH
     SPECIES     TARGET
                                                        CANCER
                                                                             [SLOPE FACTOR]           [UNIT RISK]
                                                                [EPA      ORAL    INHALATION      ORAL    INHALATION  REFERENCE
                                                                GROUP]  (•g/kg/day)1(«8/ko/day)1    (i^/L)1  (ug/cu •) '
METOLACHLOR
                         051218-45-2
                                                                                                                             010951
MIREX                                002385-85-5
        ORAL:  DIET       2 YEARS                                           B2
                        RAT,  MALE     LIVER               ADENOMA/
                                                         CARCINOMA,
                                                         COMBINED

        EPA GROUP COMMENT:   UNDER REVIEW,  CLASSIFICATION SUBJECT TO CHANGE.
        GENERAL  COMMENT:  ALSO SEE HEAST TABLE  1: SUBCHRONIC AND CHRONIC TOXICIir (OTHER THAN  CARCINOGENIC!It).
                                                                                                          010952
TCDD, 2,3,7,8-
        ORAL:  DIET
     720 DAYS
     RAT
                                 001746-01-6

                             RESPIRATORY SYSTEM   TUMORS
                             LIVER               TUMORS
                                                     B2
                                                             1.5E+5     1.5E+5
                                                                                                         4.5E+0    3.3E-5     005128
                                                                                                                   (pg/cu m) '
        INHALATION  [SLOPE]  COMMENT:  SEE APPENDIX A-II,  DOSE CONVERSIONS ON HEAST.
        ORAL [SLOPE] COMMENT:  UNDER REVIEW, NUMBER SUBJECT TO CHANGE.
        INHALATION  [UNIT RISK] COMMENT:  UNDER REVIEW,  NUMBER SUBJECT TO CHANGE. BASED ON ROUTE TO ROUTE EXTRAPOLATION. AN ABSORPTION FACTOR OF  75%
        IS USED  TO CALCULATE THE UNIT RISK FROM THE SLOPE  FACTOR.
TETRACHLOROETHANE, 1,1,1,2-
        ORAL:  GAVAGE     103 WEEKS
                                                     IRIS    IRIS
                                                                       2.6E-2
                                                                                      IRIS
                                          000630-20-6

                             LIVER               TUMOR

INHALATION SLOPE COMMENT:   BASED  ON ROUTE TO ROUTE EXTRAPOLATION.  SEE APPENDIX A-II, DOSE CONVERSIONS ON HEAST.
                                                                                                IRIS
                                                                                                          010302
TRICHLOROPROPANE, 1,2,3-
        ORAL:  GAVAGE
                        RAT, MALE
                             000096-18-4

                  MUTIPLE SITES
                                                                B2
                                                                        7E+0
                                                                                                 2E-A
                                                TUMORS,
                                                BENIGN/MALIGNANT
                                                COMBINED
        EPA GROUP COMMENT:    UNDER REVIEW,  CURRENT CLASSIFICATION SUBJECT TO CHANGE.
        GENERAL COMMENT:  ALSO  SEE HEAST TABLE 1: SUBCHRONIC AND CHRONIC TOX1CITY (OTHER THAN CARCINOGENICITY).
                                                                                                                     010849
IRIS,  EPA'S  INTEGRATED RISK  INFORMATION SYSTEM IS UPDATED MONTHLY. FURTHER  INFORMATION: RISK INFORMATION  HOTLINE: (513)  569-7254.
                                                                                                                                          3-3

-------

-------
                             REFERENCES FOR HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY
                                                (OTHER THAN CARCINOGENICITY)                             November 1993


ACRYLONITRILE                                       000107-13-1
       010939
             TANDON, R., DK SAXENA, SV CHANDRA, PK SETH, SP SRIVASTAVA. 1988. TESTICULAR EFFECTS OF ACRYLONITRILE IN MICE
             TOXICOLOGY LETTERS 42: 56-63.

             BIODYNAMICS, INC. 1980. A TWENTY-FOUR MONTH ORAL TOXICITY/CARCINOGENICITY STUDY OF ACRYLONITRILE ADMINISTERED TO
             SPARTAN RATS IN THE DRINKING WATER, VOL 1-2. PREPARED BY BIODYNAMICS, INC., DIVISION OF BIOLOGY AND SAFETY EVALUATION,
             EAST MILLSTONE, NJ, FOR MONSANTO COMPANY, ST. LOUIS, MO.

             US EPA. 1993. RfD/RfC WORK GROUP


AROCHLOR1248                                       012672-29-6
       010940
             US EPA. 1993. RfD/RfC WORK GROUP.


ATRAZINE
       010866
             CIBA-GEIGY CORPORATION. 1986. MRID NO 00141874, 00157876, 00168930, 40629302. HED DOC NO 006940, 006937. AVAILABLE
             FROM EPA. WRITE TO FOI, EPA, WASHINGTON, DC.

             CIBA GEIGY CORPORATION, AGRICULTURAL DIVISION. 1987. MRID NO 40431301, 41293802. HED DOC NO 006718, 006937, 007647
             AVAILABLE FROM EPA. WRITE TO FOI, EHA, WASHINGTON, DC.

             US EPA. 1993. RfD/RfC WORK GROUP.


BARIUM CYANIDE                                      000542-62-1
       010941
             US EPA. 1993. RfD/RfC WORK GROUP.
                                                                                                                     R1-1

-------
                             REFERENCES FOR HEAST TABLE 1: SUBCHRONIC AND CHRONIC TOXICITY
                                                (OTHER THAN CARCINOGENICITY)                              November 1993


BENZENETHIOL                                  000108-98-5
(THIOBENZENE)
       010942
             AMERICAN BIOGENICS CORP. 1989. NINETY-DAY GAVAGE STUDY IN ALBINO RATS USING THIOPHENOL. PREPARED BY DYNAMAC CORP
             OF ROCKVILLE, MD FOR THE US EPA OFFICE OF SOLID WASTE.

             FAIRCHILD, EJ AND HE STOKINGER. 1958. TOXICOLOGIC STUDIES ON ORGANIC SULFUR COMPOUNDS. 1. ACUTE TOXICITY OF SOME
             ALIPHATIC AND AROMATIC THIOLS (MERCAPTANS). AM IND HYG ASSOC J. 19: 171-189.

             US EPA. 1993. RfD/RfC WORK GROUP.


BORON, ELEMENTAL                                   007440-42-8
       006269
             GARABRANT DH, L BERNSTEIN,  JM PETERS ET AL. 1986. RESPIRATORY EFFECTS OF BORAX DUST. BR J IND MED. 42: 831-837.

             US EPA. 1991. HEALTH AND ENVIRONMENTAL EFFECTS DOCUMENT FOR BORON AND BORON COMPOUNDS. PREPARED BY THE OFFICE OF
             HEALTH AND ENVIRONMENTAL  ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI,  OH, FOR THE OFFICE
             OF SOLID WASTE AND EMrRGENCY RESPONSE, WASHINGTON, DC.

       006272
             WEIR RJ, JR AND RS FISHER. 1972. TOXICOLOGIC STUDIES ON BORAX AND BORIC ACID. FOXICOL APPL PHARMACOL. 23(31: 361 364

             US EPA. 1987. HEALTH EFFECTS ASSESSMENT FOR BORON AND COMPOUNDS. PREPARED BY THE OFFICE OF HEALTH AND
             ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH FOR THE OFFICE OF
             EMERGENCY AND REMEDIAL RESPONSE, WASHINGTON, DC.

             US EPA. 1989. RfD/RfC WORK  GROUP.
                                                  t
             US EPA. 1993. REVISED AND UPDATED DRINKING WATER QUANTIFICATION OF TOXICOLOGIC EFFECTS FOR BORON. PREPARED BY THE
             OFFICE OF HEALTH AND ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH FOR
             THE OFFICE OF WATER, WASHINGTON, DC.
                                                                                                                     R1 2

-------
                              REFERENCES FOR HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY
                                                (OTHER THAN CARCINOGENICITY)                              November 1993


BROMOMETHANE                                           000074-83-9
       010860
             REUZEL, PQJ, CF KUPER, HC DREEF-VAN DER MEULEN, VMH HOLLANDERS. 1987. CHRONIC (29 MONTH) INHALATION TOXICITY AND
             CARCINOGENICITY STUDY OF METHYL BROMIDE IN RATS. REPORT NO. V86.469/221044. NETHERLANDS ORGANIZATION FOR APPLIED
             SCIENTIFIC RESEARCH, DIVISION FOR NUTRITION AND FOOD RESEARCH, TNO. EPA/OTS DOCUMENT #86-8700001202.

             REUZEL, PGJ, HC DREEF-VAN DER MEULEN, VMH HOLLANDERS, CF KUPER, VJ FERON, CA VAN DER HEIJDEN 1991  CHRONIC
             INHALATION TOXICITY AND CARCINOGENICITY STUDY OF METHYL BROMIDE IN WISTAR RATS. FOOD CHEM TOXICOL. 29(11: 31 39

             US EPA. 1991. RfD/RfC WORK GROUP.

       010861
             DANSE LH, FL VAN VELSEN AND CA VAN DER HEIJDEN 1984.  METHYL BROMIDE. CARCINOGENIC EFFECTS IN THE RAT FORESTOMACH
             TOXICOL APPL PHARMACOL. 72: 262-271.

             US EPA. 1987. HEALTH EFFECTS ASSESSMENT FOR BROMOMETHANE. PREPARED BY THE OFFICE OF HEALTH AND ENVIRONMENTAL
             ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH FOR THE OFFICE OF EMERGENCY AND REMEDIAL
             RESPONSE, WASHINGTON,  DC.

             US EPA. 1986. HEALTH AND ENVIRONMENTAL EFFECTS PROFILE FOR METHYL BROMIDE. PREPARED BY THE OFFICE OF HEALTH AND
             ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH FOR THE OFFICE OF SOLID
             WASTE AND EMERGENCY RESPONSE, WASHINGTON, DC.

             US EPA. 1988. RfD/RfC WORK GROUP.

             US EPA. 1993. REVISED AND UPDATED DRINKING WATER QUANTIFICATION OF TOXICOLOGIC EFFECTS FOR BROMOMETHANE. PREPARED
             BY THE OFFICE OF HEALTH AND ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH
             FOR THE OFFICE OF WATER, WASHINGTON, DC.

       010880
             US EPA. 1992. SUPERFUND HEALTH RISK TECHNICAL SUPPORT CENTER.
                                                                                                                       R1 3

-------
                             REFERENCES FOR HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY
                                                (OTHER THAN CARCINOGENICITY)                             November 1993


CHROMIUM(III)                                         016065-83-1
       006731
             IVANKOVIC S AND R PREUSSMAN.  1976. ABSENCE OF TOXIC AND CARCINOGENIC EFFECTS AFTER ADMINISTRATIONS OF HIGH DOSES
             OF CHROMIC OXIDE PIGMENT IN SUBACUTE AND LONG-TERM FEEDING EXPERIMENTS IN RATS. FOOD COSMET TOXICOL 13:347 361.

             US EPA. 1984. HEALTH EFFECTS ASSESSMENT FOR TRIVALENT CHROMIUM. PREPARED BY THE OFFICE OF HEALTH AND ENVIRONMENTAL
             ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH FOR THE OFFICE OF EMERGENCY AND REMEDIAL
             RESPONSE, WASHINGTON, DC.

             US EPA.  1986. RfD/RfC WORK GROUP

       010886
             US EPA 1992. SUPERFUND HEALTH RISK TECHNICAL SUPPORT CENTER.


CRESOL, P                                           000106445
(METHYLPHENOL, 4 )
       010616
             CMA (CHEMICAL MANUFACTURERS' ASSOCIATION). 1988. DEVELOPMENTAL TOXICITY EVALUATION OF O-, M- OR P-CRESOL
             ADMINISTERED BY GAVAGE TO NEW ZEALAND WHITE RABBITS. FINAL PROJECT REPORT 61-608. FICHE NO. OTS0617696.

             DEITZ, D, AND LT MULLIGAN. 1988. SUBCHRONIC TOXICITY OF P-CRESOL IN SPRAGUE-DAWLEY RATS; MBA CHEMICAL NO 26. PREPARED
             BY RESEARCH  TRINAGLE INSTITUTE, RESEARCH TRIANGLE PARK, NC. PREPARED FOR EPA, WASHINGTON, DC.

             US EPA. 1993. RfD/RfC WORK GROUP.


       010890
             US EPA. 1991. RfD/RfC WORK GROUP.
                                                                                                                    R1-4

-------
                              REFERENCES FOR HEAST TABLE 1: SUBCHRONIC AND CHRONIC TOXICITY
                                                 (OTHER THAN CARCINOGENICITY)                              November 1993


DICAMBA                                               001918-00-9
       010945
              GOLDENTHAL, El, DC JESSUP AND DE RODWELL. 1978. TERATOLOGY  STUDY IN RABBITS: IRDC NO. 163 436. (UNPUBLISHED STUDY
              RECEIVED MARCH 6, 1979 UNDER 876-36. PREPARED BY INTERNATIONAL RESEARCH AND DEVELOPMENT CORP., SUBMITTED BY
              "ELSICOL CHEMICAL CORP., CHICAGO, IL. CDL:23799B-E). CITED AS VELSICOL CHEMICAL CORPORATION (1978) IN U.S. EPA (1993).
              MRID 00028236.

              US EPA.  1993. REVISED AND UPDATED  DRINKING WATER QUANTIFICATION OF TOXICOLOGIC EFFECTS FOR DICAMBA PREPARED BY  THE
              OFFICE OF HEALTH AND ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH FOR
              THE OFFICE OF WATER, WASHINGTON,  DC.

              US EPA  1988 RFD/RFC WORK GROUP


DICHLOROPROPENE, 1,3-                                000542-75-6
(TELONE II)
       005901
              DOW CHEMICAL CO. 1973. MRID NOS. 00067977, 0039684.  US EPA, WASHINGTON, DC

              US EPA.  1989. HEALTH AND ENVIRONMENTAL EFFECTS DOCUMENT FOR 1,3 DICHLOROPROPENE. PREPARED BY THE OFFICE OF HEALTH
              AND ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI. OH FOR THE OFFICE OF SOLID
              WASTE AND EMERGENCY RESPONSE, WASHINGTON, DC.

              US EPA.  1987. RfD/RfC WORK  GROUP.

              US EPA.  1993. REVISED AND UPDATED  DRINKING WATER QUANTIFICATION OF TOXICOLOGIC EFFECTS FOR 1,3 DICHLOROPROPENE
              PREPARED BY THE OFFICE OF HEALTH AND ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE,
              CINCINNATI, OH FOR THE OFFICE OF WATER, WASHINGTON,  DC.


       010351  LOMAX, LG, WT STOTT, KA JOHNSON, ET AL. 1989. THE CHRONIC TOXICITY AND ONCOGENICITY OF INHALED TECHNICAL GRADE
            1,3-DICHLOROPROPENE IN RATS AND MICE. FUND APPL TOXICOL. 10:214.

            US EPA  1989  HEALTH AND ENVIRONMENTAL EFFECTS DOCUMENT FOR 1,3-DICHLOROPROPENE. PREPARED BY THE OFFICE OF HEALTH
            AND ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH FOR THE OFFICE OF SOLID
            WASTE AND EMERGENCY RESPONSE, WASHINGTON, DC.

            US EPA. 1990. RfD/RfC WORK GROUP.


                                                                                                                       R1 b

-------
                              REFERENCES FOR HEAST TABLE 1: SUBCHRONIC AND CHRONIC TOXICITY
                                                 (OTHER THAN CARCINOGENICITY)                             November 1993


MANGANESE                                            007439-96-5
       010861
             WHO (WORLD HEALTH ORGANIZATION).  1973. TRACE ELEMENTS IN HUMAN NUTRITION: MANGANESE. REPORT OF A WHO EXPERT
             COMMITTEE. TECHNICAL REPORT SERVICE, 532, WHO, GENEVA, SWITZERLAND. PP 34 36.

             SCHROEDER, HA, JJ BALASSA AND IH TIPTON. 1966. ESSENTIAL TRACE METALS IN MAN: MANGANESE  A STUDY IN HOMEOSTASIS  J
             CHRON DIS. 19: 64B-B71.

             NRC (NATIONAL RESEARCH COUNCIL). 1989. RECOMMENDED DIETARY ALLOWANCES,  10TH ED  FOOD AND NUTRITION BOARD
             NATIONAL RESEARCH COUNCIL, NATIONAL ACADEMY PRESS, WASHINGTON, DC. PP 230-236.

             US EPA.  1992. RfD/RfC WORK GROUP.

             US EPA. 1993. DRINKING WATER CRITERIA DOCUMENT FOR MANGANESE. PREPARED BY THE OFFICE OF HEALTH AND ENVIRONMENTAL
             ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH FOR THE OFFICE OF WATER, WASHINGTON, DC.


       010860
             KONDAKIS, XG, N MAKRIS, M LEOTSINIDIS, M PRINOU AND T  PAPAPETROPOULOS.  1989. POSSIBLE HEALTH EFFECTS OF HIGH
             MANGANESE CONCENTRATION IN DRINKING WATER. ARCH ENVIRON HEALTH. 44: 176 178.

             US EPA.  1992. RfD/RfC WORK GROUP.

             US EPA. 1993. DRINKING WATER CRITERIA DOCUMENT FOR MANGANESE. PREPARED BY THE OFFICE OF HEALTH AND ENVIRONMENTAL
             ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH FOR THE OFFICE OF WATER, WASHINGTON, DC.


       010366
             ROELS, H, R LAWERYS, J-P BUCHET ET AL. 1989. EPIDEMIOLOGICAL SURVEY AMONG WORKERS EXPOSED TO MANGANESE. EFFECTS ON
             LUNG, CENTRAL NERVOUS SYSTEM, AND SOME BIOLOGICAL INDICES.  AM J IND MED. 11:307-327.

             US EPA. 1984. HEALTH ASSESSMENT DOCUMENT FOR MANGANESE. PREPARED BY THE OFFICE OF HEALTH AND ENVIRONMENTAL
             ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH. EPA 600/8/83-01 3F. NTIS PB84-229964.

             US EPA.  1990. RfD/RfC WORK GROUP.

-------
                             REFERENCES FOR HEAST TABLE 1: SUBCHRONIC AND CHRONIC TOXICITY
                                               (OTHER THAN CARCINOGENICITY)                             November 1993


METHYL ETHYL KETONE                                    000078-93-3
       010863
             COX, GE. 1976. TOXICITY STUDIES IN RATS WITH 2-BUTANOL: INCLUDING GROWTH, REPRODUCTION, AND TERATOGENIC
             OBSERVATIONS. FOOD AND DRUG RESEARCH LABORATORIES, INC. (91 MAR R 16731

             US EPA. 1992. RFD/RFC WORK GROUP.


       010845
             SCHWETZ, BA, TJ MAST, RJ WEIGEL, ET AL. 1991. DEVELOPMENTAL TOXICITY OF INHALED METHYL ETHYL KETONE IN MICE FUND APPL
             TOXICOL. 16: 742-748.

             MAST,  TJ, JA DILL, JJ EVANOFF, ET AL  1989. INHALATION  DEVELOPMENTAL TOXICOLOGY STUDIES. TERATOLOGY STUDY OF METHYL
             ETHYL  KETONE IN MICE. FINAL REPORT PREPARED BY PACIFIC NORTHWEST LABORATORY. BATELLE MEMORIAL INSTITUTE, FOR THE
             NATIONAL TOXICOLOGY PROGRAM, WASHINGTON, DC  PNL 6833 UC 4O8.

             US EPA. 1991. RfD/RfC WORK GROUP.


METHYL ETHYL KETONE PEROXIDE                       001 338-23-4
       010948
             US EPA. 1993. RfD/RfC WORK GROUP.


METHYL ISOBUTYL KETONE                                    000108-10-1
       010949
             MICROBIOLOGICAL ASSOCIATES. 1986. SUBCHRONIC TOXICITY OF METHYL ISOBUTYL KETONE IN SPRAGUE-DAWLEY RATS. PERFORMED
             FOR RESEARCH TRIANGLE INSTITUTE, PO BOX 12194, RESEARCH TRIANGLE PARK, NC, 27709. FINAL REPORT. STUDY NO 522104.

             US EPA. 1993. RfD/RfC WORK GROUP.
                                                                                                                   R1 7

-------
                              REFERENCES FOR HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY
                                                 (OTHER THAN CARCINOGENICITY)                              November 1993


METOLACHLOR                                        051218-45-2
       010960
              TISDEL M, T JACKSON, P MACWILLIAMS ET AL. 1983. TWO-YEAR CHRONIC ORAL TOXICITY AND ONCOGENICITY STUDY WITH
              METOLACHLOR IN ALBINO RATS: STUDY NO. 80030. FINAL REPORT. (UNPUBLISHED STUDY RECEIVED MAY 24. 1983 UNDER 100 587.
              PREPARED BY HAZLETON RALTECH, INC., SUBMITTED BY CIBA-GEIGY CORP., GREENSBORO, NC: CDL:2B0369-A, 260370, 260371.
              260272,  269373, 269374, 259376.) REFERRED TO AS CIBA-GEIGY,  1983 IN U.S. EPA (1993). MRID 00129377.

              SMITH SH, CK O'LOUGHLIN, CM SALAMON ET AL. 1981. TWO-GENERATION REPRODUCTION STUDY IN ALBINO RATS WITH
              METOLACHLOR TECHNICAL: STUDY NO. 460 0272. FINAL REPORT. (UNPUBLISHED STUDY RECEIVED SEPTEMBER 30, 1981 UNDER 100
              697. PREPARED BY WHITTAKER CORP., SUBMITTED BY CIBA-GEIGY CORP.. GREENSBORO, NC. CDL:246969-A, 246960, 246961.)
              REFERRED TO AS CIBA-GEIGY (1981) IN U.S. EPA (1993). MRID 00080897.

              US EPA.  1993. REVISED AND UPDATED DRINKING  WATER QUANTIFICATION OF  TOXICOLOGIC EFFECTS FOR METOLACHLOR  PREPARED
              BY THE OFFICE OF HEALTH AND ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH
              FOR THE  OFFICE OF WATER, WASHINGTON, DC.
NICKEL CYANIDE                                       000557-19-7
       010963
             US EPA. 1993. RfD/RfC WORK GROUP


OSMIUM TETROXIDE                                    020816-12-0
       010964
             US EPA. 1993. RfD/RfC WORK GROUP.


SIMAZINE                                              000122-34-9
       010966
             CIBA-GEIGY CORP. 1988. MRID NO 40614406, HED DOCUMENT NO 007240, 007449. AVAILABLE FROM EPA. WRITE TO FOI, EPA,
             WASHINGTON, DC 20460.

             US EPA. 1991. RfD/RfC WORK GROUP.
                                                                                                                      R1 8

-------
                             REFERENCES FOR HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY
                                               (OTHER THAN CARCINOGENICITY)                             November 1993


TETRACHLOROETHANE, 1,1,1,2-                                000630-20-6
       010407
             NTP (NATIONAL TOXICOLOGY PROGRAM). 1983. CARCINOGENESIS STUDIES OF 1,1,1,2-TETRACHLOROETHANE IN F344/N RATS AND
             B6C3F1 MICE. NTP, WASHINGTON, DC.

             US EPA. 1987. RfD/RfC WORK GROUP.

             US EPA. 1993. REVISED AND UPDATED DRINKING WATER QUANTIFICATION OF TOXICOLOGIC EFFECTS FOR TETRACHLGPOETHANE,
             1,1,1,2-. PREPARED BY THE OFFICE OF HEALTH AND ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT
             OFFICE, CINCINNATI, OH FOR THE OFFICE OF WATER, WASHINGTON,  DC.


THALLIC OXIDE                                        00131432-5
       010956
             US EPA. 1993. RfD/RfC WORK GROUP.


THALLIUM SELENITE                                   01 2039-52-0
       010967
             US EPA. 1993. RfD/RfC WORK GROUP.
                                                                                                                   R1-9

-------
                             REFERENCES FOR HEAST TABLE 1:  SUBCHRONIC AND CHRONIC TOXICITY
                                                (OTHER THAN CARCINOGENICITY)                             November 1993


TRICHLOROBENZENE. 1,2.4-                             000120-82-1
       010968
             KOCIBA, RJ, BKL LEONG, RE HEFNER, JR. 1981. SUBCHRONIC TOXICITY STUDY OF 1,2,4-TRICHLOROBENZENE IN THE RAT, RABBIT AND
             BEAGLE DOG. DRUG AND CHEMICAL TOXICOLOGY. 4(3): 229 249.

             COATE, WB, TR LEWIS, WM BUSEY.  1977. CHRONIC INHALATION EXPOSURE OF RATS RABBITS AND MONKEYS TO 1,2,4
             TRICHLOROBENZENE. ARCHIVES OF ENVIRONMENTAL HEALTH. 32(8): 249-266.

             COTE, M, I CHU, DC VILLENEUVE, VE SECOURS, VE VALLI. 1988. TRICHLOROBENZENES: RESULTS OF A THIRTEEN WEEK FEEDING STUDY
             IN THE RAT. DRUG AND CHEMICAL TOXICOLOGY. 11(1): 11-28.

             US EPA. 1993. RfD/R»C WORK GROUP.


       010606
             ROBINSON, KS, RJ KAVLOCK, N CHERNOFF AND E GRAY. 1981. MULTIGENERATION STUDY OF TRICHLOROBENZENE IN RATS. J TOXICOL
             ENVIRON HEALTH. 8: 489-600.

             US EPA. 1991. DRINKING WATER CRITERIA DOCUMENT FOR 1,2,4- TRICHLOROBENZENE. PREPARED BY THE OFFICE OF HEALTH AND
             ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH FOR THE OFFICE OF DRINKING
             WATER, WASHINGTON, DC.

             US EPA.  1991.  RfD/RfC WORK GROUP.

-------
                                              REFERENCES FOR HEAST TABLE 3: CARCINOGENICITY
                                                                                                                                     November  1993
CYANAZINE
        010944
                                               n
                                          AND CO.
           021725-46-2
TOX'C'TV/OHCOCEMICITY STUDY WITH CYANAZINE  (INR-1057) 2-YEAR FEEDING STUDY  IN RATS. PREPARED
                  US EPA. 1993. REVISED AND UPDATED  DRINKING WATER QUANTIFICATION  OF TOXICOLOGIC EFFECTS FOR CYANAZINE  PREPARED BY THE OFFICE OF
                  HEALTH AND  ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA  AND ASSESSMENT OFFICE, CINCINNATI,  OH  FOR THE OFFICE OF WATER,
                  WASH I NGTON t DC*
DIBROMO-3-CHLOROPROPANE, 1,2
                      000096-12-8
        010519
                  NTP (NATIONAL TOXICOLOGY PROGRAM).  1982. CARCINOGENESIS  BIOASSAY OF 1.2-DIBROMO-3-CHLOROPROPANE  (CAS NO 96-12-8) IN F344  RATS AND
                  B6C3F1  MICE  (INHALATION STUDY). NTP-TR-NO 81-21.

                  US EPA.  1989. CARCINOGEN RISK ASSESSMENT VERIFICATION ENDEAVOR  (CRAVE) WORK GROUP.


        010484    HAZELTON  LABORATORIES,  INC.  1977. 104 WEEK DIETARY STUDY IN RATS, 1.2-DIBROMO-3 CHLOROPROPANE  (DBCP). FINAL REPORT   UNPUBLISHED
                  REPORT  SUBMITTED TO DOW CHEMICAL CO., MIDLAND, MI. OCTOBER 29,  1977.

                  US EPA.  1988. DRINKING  WATER CRITERIA DOCUMENT FOR DIBROMOCHLOROPROPANE.  PREPARED BY  THE OFFICE OF HEALTH AND ENVIRONMENTAL
                  ASSESSMENT, ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI,  OH  FOR THE OFFICE OF DRINKING WATER  WASHINGTON  DC
                  ECAO-CIN-410.

                  US EPA.  1988. ASSESSMENT OF THE CARCINOGENIC POTENTIAL OF 1.2-DIBROMO-3-CHLOROPROPANE  (DBCP).  PREPARED BY THE CARCINOGEN  ASSESSMENT
                  GROUP.  AVAILABLE THROUGH KCRA/SUPERFUND DOCKET.


DICHLOROPROPENE, 1,3-                                     000542-75-6
(TELONE  II)
        010946    NTP (NATIONAL TOXICOLOGY PROGRAM). 1985. TOXICOLOGY AND  CARCINOGENESIS STUDIES OF TELONE II  IN F344/N RATS AND B6C3F1  MICE  US DEPT
                  HEALTH  AND HUMAN SERVICES, TECH REPORT SER NO 269.

                  US EPA.  1993. CARCINOGEN RISK ASSESSMENT VERIFICATION ENDEAVOR  (CRAVE) WORK GROUP.

                  US EPA.  1993. REVISED AND UPDATED DRINKING WATER QUANTIFICATION OF TOXICOLOGIC EFFECTS FOR 1,3-DICHLOROPROPENE.  PREPARED  BY THE
                  OFFICE  OF HEALTH AND ENVIRONMENTAL ASSESSMENT, ENVIRONMENTAL CRITERIA  AND ASSESSMENT OFFICE, CINCINNATI,  OH FOR  THE  OFFICE OF
                  WATER,  WASHINGTON,  DC.
        010104    LOMAX LG, WT STOTT,  KA JOHNSON, LL CALHOUN, BL YANO AND  JF QUAST. 1989.  THE CHRONIC  TOXICITY AND ONCOGENICITY OF  INHALED TECHNICAL
                  GRADE 1,3-DICHLOROPROPENE  IN RATS AND MICE. FUND APPL  TOXICOL.12: 418-431.

                  US EPA. 1989. HEALTH AND ENVIRONMENTAL EFFECTS DOCUMENT  FOR 1,3- DICHLOROPROPENE.  PREPARED BY THE OFFICE OF HEALTH  AND
                  ENVIRONMENTAL ASSESSMENT,  ENVIRONMENTAL CRITERIA AND ASSESSMENT OFFICE, CINCINNATI, OH  FOR THE OFFICE OF SOLID WASTE  AND EMERGENCY
                  RESPONSE, WASHINGTON DC.

                  US EPA.  1987.  CARCINOGEN RISK ASSESSMENT VERIFICATION  ENDEAVOR (CRAVE) WORK GROUP.
                                                                                                                                             R3-1

-------
                                              REFERENCES  FOR HEAST TABLE 3: CARCINOGENICITY                         November 1993




ETHYLENE THIOUREA                                         000096-45-7
        010947    NTP  (NATIONAL TOXICOLOGY  PROGRAM). 1992.  NTP  TECHNICAL REPORT ON THE  PERINATAL TOXICOLOGY  AND CARCINOGENESIS STUDIES  OF ETHYLENE
                  THIOUREA 
-------
                                           REFERENCES FOR HEAST TABLE 3:  CARCINOGENICITY
                                                                                                                             November 1993
TRICHLOROPROPANE, 1,2,3-                                        000096-18-4
        010849    NIP (NATIOMAL TOXICOLOGY PROGRAM). 1991.  NTP TECHNICAL  REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF 1  2 3-
                 TRICHLOROPROPANE (CAS NO 96-16-4)  IN F344/N RATS AND B6C3F1 MICE (GAVAGE STUDIES). BOARD DRAFT NTP TR 384. NIH PUB NO 91-2839. US
                 DEPT OF HEALTH AND HUMAN SERVICES, PUBLIC HEALTH SERVICE, NIH, RESEARCH TRIANGLE PARK,  NC.

                 US EPA. 1993. CARCINOGEN RISK ASSESSMENT  VERIFICATION ENDEAVOR (CRAVE) WORK GROUP.
    o
                                                                                                                                     R3-3

-------